{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:55:50Z","timestamp":1791896150825,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672160"],"award-info":[{"award-number":["81672160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2016YFC1102005"],"award-info":[{"award-number":["2016YFC1102005"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Our aim was to investigate the clinical efficacy and complications of antibiotic treatment regimens for patients with bone infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analysed patients with bone infection admitted to our hospital between March 2013 and October 2018. After surgical debridement was performed, the patients were divided into three groups: IV group (intravenous antibiotics for 2 weeks); oral group (intravenous antibiotics for 2 weeks followed by oral antibiotics for 4 weeks); and rifampicin group (intravenous antibiotics for 2 weeks followed by oral antibiotics plus rifampicin for 4 weeks). The infection control rate and complications were compared among the three groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 902 patients were enrolled. The infection sites included 509 tibias, 228 femurs, 32 humeri, 23 radii and ulnae, 40 calcanei, and 47 miscellaneous sites, as well as 23 multiple-site infections. After at least 6 months of follow-up, 148 (16.4%) patients had an infection recurrence. The recurrence rate of the IV group was 17.9%, which was not significantly higher than the recurrence rates of the oral group (10.1%) and rifampicin group (10.5%),\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.051. The incidence of abnormal alanine aminotransferase (ALT) levels in the IV group was 15.1%, which was lower than that in the oral group (18.0%) and rifampicin group (27.4%),\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.026. The rates of proteinuria in the three groups were 3.2, 4.5, and 9.3%, respectively,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.020.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>After debridement of bone infection, short-term antibiotic treatment regimens might offer similar rates of infection eradication while avoiding the risk of renal and hepatic damage associated with prolonged antibiotic use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>The level of clinical relevance<\/jats:title>\n                    <jats:p>Stage III.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-020-03214-4","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T11:04:02Z","timestamp":1586257442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antibiotic treatment regimens for bone infection after debridement: a study of 902 cases"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiaohua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"issue":"3","key":"3214_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cid\/cir842","volume":"54","author":"B Spellberg","year":"2012","unstructured":"Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infection Dis. 2012;54(3):393\u2013407.","journal-title":"Clin Infection Dis"},{"key":"3214_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s13063-015-1098-y","volume":"16","author":"HK Li","year":"2015","unstructured":"Li HK, Scarborough M, Zambellas R, Cooper C, Rombach I, Walker AS, Lipsky BA, Briggs A, Seaton A, Atkins B. Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial. Trials. 2015;16:583.","journal-title":"Trials."},{"issue":"4","key":"3214_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5301\/jva.5000389","volume":"16","author":"L Valbousquet Schneider Jr","year":"2015","unstructured":"Valbousquet Schneider L Jr, Duron S, Arnaud FX, Bousquet A, Kervella Y, Bouzad C, Baccialone J, A'Teriitehau C, Potet J. Evaluation of PICC complications in orthopedic inpatients with bone infection for long-term intravenous antibiotics therapy. J Vascular Access. 2015;16(4):299\u2013308.","journal-title":"J Vascular Access"},{"issue":"11","key":"3214_CR4","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00264-011-1221-y","volume":"35","author":"T Rod-Fleury","year":"2011","unstructured":"Rod-Fleury T, Dunkel N, Assal M, Rohner P, Tahintzi P, Bernard L, Hoffmeyer P, Lew D, Uckay I. Duration of post-surgical antibiotic therapy for adult chronic osteomyelitis: a single-Centre experience. Int Orthop. 2011;35(11):1725\u201331.","journal-title":"Int Orthop"},{"issue":"Suppl 2","key":"3214_CR5","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.injury.2006.04.010","volume":"37","author":"A Trampuz","year":"2006","unstructured":"Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury. 2006;37(Suppl 2):S59\u201366.","journal-title":"Injury."},{"issue":"6","key":"3214_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jinf.2006.11.011","volume":"54","author":"NG Daver","year":"2007","unstructured":"Daver NG, Shelburne SA, Atmar RL, Giordano TP, Stager CE, Reitman CA, White AC Jr. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis. J Infection. 2007;54(6):539\u201344.","journal-title":"J Infection"},{"issue":"Suppl. 5","key":"3214_CR7","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S0020-1383(11)70128-0","volume":"42","author":"G Mouzopoulos","year":"2011","unstructured":"Mouzopoulos G, Kanakaris NK, Kontakis G, Obakponovwe O, Townsend R, Giannoudis PV. Management of bone infections in adults: the surgeon's and microbiologist's perspectives. Injury. 2011;42(Suppl. 5):S18\u201323.","journal-title":"Injury."},{"issue":"7580","key":"3214_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/bmj.38993.560984.BE","volume":"333","author":"JJ Oosterheert","year":"2006","unstructured":"Oosterheert JJ, Bonten MJ, Schneider MM, Buskens E, Lammers JW, Hustinx WM, Kramer MH, Prins JM, Slee PH, Kaasjager K, et al. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ. 2006;333(7580):1193.","journal-title":"BMJ."},{"issue":"11","key":"3214_CR9","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/340353","volume":"34","author":"DL Stevens","year":"2002","unstructured":"Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2002;34(11):1481\u201390.","journal-title":"Clin Infect Dis"},{"issue":"7616","key":"3214_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/bmj.39244.692442.55","volume":"335","author":"G Montini","year":"2007","unstructured":"Montini G, Toffolo A, Zucchetta P, Dall'Amico R, Gobber D, Calderan A, Maschio F, Pavanello L, Molinari PP, Scorrano D, et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ. 2007;335(7616):386.","journal-title":"BMJ."},{"issue":"8","key":"3214_CR11","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.arth.2019.04.009","volume":"34","author":"H Vahedi","year":"2019","unstructured":"Vahedi H, Aali-Rezaie A, Shahi A, Conway JD. Irrigation, debridement, and implant retention for recurrence of Periprosthetic joint infection following two-stage revision Total knee Arthroplasty: a matched cohort study. J Arthroplast. 2019;34(8):1772\u20135.","journal-title":"J Arthroplast"},{"issue":"6","key":"3214_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.surge.2015.12.005","volume":"14","author":"N Maffulli","year":"2016","unstructured":"Maffulli N, Papalia R, Zampogna B, Torre G, Albo E, Denaro V. The management of osteomyelitis in the adult. Surgeon. 2016;14(6):345\u201360.","journal-title":"Surgeon"},{"issue":"3","key":"3214_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.injury.2016.09.019","volume":"49","author":"WJ Metsemakers","year":"2018","unstructured":"Metsemakers WJ, Kuehl R, Moriarty TF, Richards RG, Verhofstad MHJ, Borens O, Kates S, Morgenstern M. Infection after fracture fixation: current surgical and microbiological concepts. Injury. 2018;49(3):511\u201322.","journal-title":"Injury."},{"issue":"4","key":"3214_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1056\/NEJMra1213956","volume":"370","author":"H Peltola","year":"2014","unstructured":"Peltola H, P\u00e4\u00e4kk\u00f6nen M. Acute osteomyelitis in children. N Engl J Med. 2014;370(4):352\u201360.","journal-title":"N Engl J Med"},{"issue":"6","key":"3214_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/01241398-198707060-00004","volume":"7","author":"PA Vaughan","year":"1987","unstructured":"Vaughan PA, Newman NM, Rosman MA. Acute hematogenous osteomyelitis in children. J Pediatr Orthop. 1987;7(6):652\u20135.","journal-title":"J Pediatr Orthop"},{"issue":"9431","key":"3214_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","volume":"364","author":"DP Lew","year":"2004","unstructured":"Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369\u201379.","journal-title":"Lancet"},{"key":"3214_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00003086-199903000-00008","volume":"360","author":"JT Mader","year":"1999","unstructured":"Mader JT, Shirtliff ME, Bergquist SC, Calhoun J. Antimicrobial treatment of chronic osteomyelitis. Clin Orthop Relat Res. 1999;360:47\u201365.","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"3214_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/INF.0b013e3181f55a89","volume":"29","author":"H Peltola","year":"2010","unstructured":"Peltola H, Paakkonen M, Kallio P, Kallio MJ, Osteomyelitis-Septic Arthritis Study G. Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases. Pediatric Infectious Dis J. 2010;29(12):1123\u20138.","journal-title":"Pediatric Infectious Dis J"},{"issue":"6","key":"3214_CR19","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1469-0691.2011.03643.x","volume":"18","author":"H Peltola","year":"2012","unstructured":"Peltola H, Paakkonen M, Kallio P, Kallio MJ, Group O-SS. Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial. Clin Microbiol Infect. 2012;18(6):582\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"3214_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1302\/0301-620X.94B5.28523","volume":"94","author":"J Dartnell","year":"2012","unstructured":"Dartnell J, Ramachandran M, Katchburian M. Haematogenous acute and subacute paediatric osteomyelitis: a systematic review of the literature. J Bone Joint Surgery Br Vol. 2012;94(5):584\u201395.","journal-title":"J Bone Joint Surgery Br Vol"},{"issue":"8","key":"3214_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/archinte.168.8.805","volume":"168","author":"J Perlroth","year":"2008","unstructured":"Perlroth J, Kuo M, Tan J, Bayer AS, Miller LG. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med. 2008;168(8):805\u201319.","journal-title":"Arch Intern Med"},{"issue":"5","key":"3214_CR22","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1128\/AAC.39.5.1134","volume":"39","author":"J Blaser","year":"1995","unstructured":"Blaser J, Vergeres P, Widmer AF, Zimmerli W. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother. 1995;39(5):1134\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3214_CR23","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/1469-0691.12003","volume":"18","author":"P Sendi","year":"2012","unstructured":"Sendi P, Zimmerli W. Antimicrobial treatment concepts for orthopaedic device-related infection. Clin Microbiol Infection. 2012;18(12):1176\u201384.","journal-title":"Clin Microbiol Infection"},{"issue":"2","key":"3214_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s15010-012-0325-7","volume":"41","author":"Y Achermann","year":"2013","unstructured":"Achermann Y, Eigenmann K, Ledergerber B, Derksen L, Rafeiner P, Clauss M, Nuesch R, Zellweger C, Vogt M, Zimmerli W. Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study. Infection. 2013;41(2):431\u20137.","journal-title":"Infection."},{"issue":"7","key":"3214_CR25","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1128\/AAC.00047-09","volume":"53","author":"AK John","year":"2009","unstructured":"John AK, Baldoni D, Haschke M, Rentsch K, Schaerli P, Zimmerli W, Trampuz A. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother. 2009;53(7):2719\u201324.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"3214_CR26","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1128\/AAC.00120-07","volume":"51","author":"A Trampuz","year":"2007","unstructured":"Trampuz A, Murphy CK, Rothstein DM, Widmer AF, Landmann R, Zimmerli W. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. Antimicrob Agents Chemother. 2007;51(7):2540\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3214_CR27","doi-asserted-by":"crossref","first-page":"ofy331","DOI":"10.1093\/ofid\/ofy331","volume":"6","author":"U Rappo","year":"2019","unstructured":"Rappo U, Puttagunta S, Shevchenko V, Shevchenko A, Jandourek A, Gonzalez PL, Suen A, Mas Casullo V, Melnick D, Miceli R, et al. Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety. Open Forum Infectious Dis. 2019;6(1):ofy331.","journal-title":"Open Forum Infectious Dis"},{"issue":"1","key":"3214_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jbspin.2012.09.008","volume":"80","author":"G Coiffier","year":"2013","unstructured":"Coiffier G, Albert J-D, Arvieux C, Guggenbuhl P. Optimizing combination rifampin therapy for staphylococcal osteoarticular infections. Joint Bone Spine. 2013;80(1):11\u20137.","journal-title":"Joint Bone Spine"},{"issue":"21","key":"3214_CR29","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2169\/internalmedicine.52.0634","volume":"52","author":"S Chiba","year":"2013","unstructured":"Chiba S, Tsuchiya K, Sakashita H, Ito E, Inase N. Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review. Intern Med. 2013;52(21):2457\u201360.","journal-title":"Intern Med"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03214-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-020-03214-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03214-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:16:42Z","timestamp":1617736602000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-020-03214-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3214"],"URL":"https:\/\/doi.org\/10.1186\/s12891-020-03214-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.18846\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18846\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18846\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18846\/v1","asserted-by":"object"}]},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"29 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Ethics Committee of the First Affiliated Hospital of Army Medical University, PLA. All the participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All presentations provided consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"215"}}